For the Inventor, By the Inventor

Enter assignee name

Lugano, Switzerland

Altergon Sa

USPTO Granted Patents = 43

CIPO Patents = 111

EPO Patents = 40

Forward Citations = 70

Loading Chart...

Loading Chart...

108 inventors (with patents filed for the assignee):

Maurizio Marchiorri (8 out of 8 patents)

Tiziano Fossati (6 out of 6 patents)

Mario De Rosa (6 out of 15 patents)

4. Chiara Schiraldi (6 out of 6 patents)

5. Simone Carucci (5 out of 5 patents)

6. Marco Pontiggia (5 out of 5 patents)

7. Giorgio Zoppetti (5 out of 21 patents)

8. Valeria Frangione (4 out of 4 patents)

9. Arturo Lanzarotti (4 out of 4 patents)

10. Elisabetta Donati (3 out of 15 patents)

11. Andrea Maria Giori (3 out of 4 patents)

12. Lorenzo Bellorini (3 out of 3 patents)

13. Marco Pizzutti (3 out of 4 patents)

14. Alberto Bernareggi (3 out of 3 patents)

15. Nadia Puppini (3 out of 4 patents)

43 patents: Sort by Forward Citations

1. 12404089 - Container for ampoules or syringes (2025-09-02),

2. 12245989 - Plunger for a syringe-type pump for a machine for encapsulation of soft capsules, and syringe-type pump comprising one or more of said plungers (2025-03-11),

3. 12226549 - Synergistically cooperative compositions useful for soft tissue augmentation, drug delivery and related fields (2025-02-18),

4. 11717486 - Highly stable formulations of thyroid hormone in soft capsules (2023-08-08),

5. 11672963 - Device for transdermal delivery of active molecules, uses of the device and methods for producing the device and its components (2023-06-13),

6. 11351133 - Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug (2022-06-07),

7. 11344520 - Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug (2022-05-31),

8. 11324854 - Resorbable implantable device based on crosslinked glycosaminoglycans, and process for the preparation thereof (2022-05-10),

9. 11304910 - Soft gelatin capsules with pH-independent release (2022-04-19),

10. 11241382 - Administration regimen of compositions of T4 thyroid hormone with high oral absorption (2022-02-08),

11. 11235017 - Use of a vegetable extract as an active agent in the treatment of dermatological diseases (2022-02-01),

12. 11235016 - Use of a vegetal extract as an active agent in tissue re-epithelizing and cicatrizing processes (2022-02-01),

13. 11096913 - High-stability packaged solutions of T4 thyroid hormone (2021-08-24),

14. 11090271 - Soft gelatin capsules containing hydroxypropyl beta cyclodextrin with high stability (2021-08-17),

15. 10927143 - Method for decontaminating a biological material by partitioning and inactivation (2021-02-23),

ALTERGON SA is a technology-based company specializing in the development of high-tech solutions for the healthcare industry. We offer innovative products and services that aim to enhance patient care and improve medical outcomes. With a strong focus on research and development, our team of experts strives to create cutting-edge technologies that revolutionize healthcare practices. Visit our website to learn more about our company and explore our range of advanced solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

43 Patents

#2 in Lugano

#336 in Switzerland

#15,554 in the World

Lugano, Switzerland

Altergon Sa

Forward Citations = 70

108 inventors:

Maurizio Marchiorri (8 out of 8 patents)

Tiziano Fossati (6 out of 6 patents)

Mario De Rosa (6 out of 15 patents)

4. Chiara Schiraldi (6 out of 6 patents)

5. Simone Carucci (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…